Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune Hepatitis and PSC Connection.

Diego Vergani1, Giorgina Mieli-Vergani

  • 1Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, Denmark Hill, London SE5 9RS, UK. diego.vergani@kcl.ac.uk

Clinics in Liver Disease
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Real Is Seronegative Autoimmune Hepatitis?

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

JHEP reports : innovation in hepatology·2026
Same author

The Geoepidemiology of Autoimmune Hepatitis.

Clinical reviews in allergy & immunology·2026
Same author

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

European journal of gastroenterology & hepatology·2026
Same author

Can we cure autoimmune hepatitis?

Current opinion in immunology·2025
Same author

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.

Journal of autoimmunity·2025
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) share chronic liver inflammation and autoimmune markers. Evidence suggests they may be part of the same immune-mediated disease spectrum, warranting further research.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are chronic liver diseases.
  • Both conditions exhibit liver inflammation and positive autoimmune serology.
  • Key differences include gender distribution and the nature of bile duct damage.

Purpose of the Study:

  • To explore the connection between AIH and PSC.
  • To investigate the potential for AIH and PSC to be part of a shared disease spectrum.
  • To highlight the immune-mediated nature of both conditions.

Main Methods:

  • Comparative analysis of clinical and serological features of AIH and PSC.
  • Review of existing evidence on the pathogenesis of AIH and PSC.

Related Experiment Videos

  • Discussion of potential disease overlap and progression.

    • Main Results:

    • AIH and PSC share common features like chronicity and liver inflammation.
    • Distinct differences exist in gender prevalence and bile duct pathology.
    • Evidence supports an immune-mediated etiology for both diseases.

    Conclusions:

    • AIH and PSC may represent different manifestations within the same disease spectrum.
    • Further research is needed to understand the frequency of AIH progression to PSC.